SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-056196
Filing Date
2024-05-09
Accepted
2024-05-09 06:07:16
Documents
63
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ck0001991792-20240331.htm   iXBRL 10-Q 1227256
2 EX-31.1 ck0001991792-ex31_1.htm EX-31.1 14191
3 EX-31.2 ck0001991792-ex31_2.htm EX-31.2 13997
4 EX-32.1 ck0001991792-ex32_1.htm EX-32.1 8696
5 EX-32.2 ck0001991792-ex32_2.htm EX-32.2 8771
  Complete submission text file 0000950170-24-056196.txt   5457319

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ck0001991792-20240331.xsd EX-101.SCH 908032
67 EXTRACTED XBRL INSTANCE DOCUMENT ck0001991792-20240331_htm.xml XML 743319
Mailing Address 400 SPECTRUM CENTER DRIVE SUITE 2040 IRVINE CA 92618
Business Address 400 SPECTRUM CENTER DRIVE SUITE 2040 IRVINE CA 92618 (949) 419-6203
CG Oncology, Inc. (Filer) CIK: 0001991792 (see all company filings)

IRS No.: 371611499 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41925 | Film No.: 24928358
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)